Arsenical Keratosis Clinical Trial
Official title:
Selenite in the Detoxification of Arsenic and the Prevention of Arsenical Melanosis and Cancers Amongst Bangladeshi Arsenicosis Patients: A 48-week, Randomized, Double-blinded, Placebo-controlled Phase III Trial
Context: Approximately 100 million people throughout the world consume water contaminated
with arsenic at levels above carcinogenic thresholds, including 40 million in Bangladesh
alone, with up to one-fourth of deaths attributed to arsenic exposure in the worst-affected
regions. There are no proven therapies for treating chronic arsenic toxicity or for
preventing arsenical cancers. Selenium has been known to counter arsenic toxicity in a
variety of animal models. The investigators have recently shown in animals and humans that
this effect is mediated by the formation of [(GS)2AsSe]- , the seleno-bis(S-glutathionyl)
arsinium ion, which is then rapidly excreted via the hepatobiliary system. Concurrently, two
Phase II studies in China and Bangladesh have suggested clinical benefit to selenium
supplementation in arsenicosis patients.
Objective: To assess whether daily selenium supplementation counters arsenic toxicity in
patients exposed to drinking water arsenic. If proven effective, selenium supplementation
might be safely and cost-effectively implemented in the worst-affected localities.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03127670 -
Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion
|
Phase 2 | |
Completed |
NCT01735097 -
Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis
|
N/A | |
Completed |
NCT01731756 -
Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis
|
N/A | |
Completed |
NCT01752972 -
Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic
|
N/A |